NCT06760598

Brief Summary

To determine the impact of thoracic hyperkyphosis, sarcopenia and quadriceps muscle thickness evaluated by ultrasonography (USG) on balance, fall risk and functional parameters in women with postmenopausal osteoporosis, to assess their interrelationships and to compare the clinical characteristics of sarcopenia and thoracic hyperkyphosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

December 27, 2024

Last Update Submit

January 6, 2025

Conditions

Keywords

muscle thicknesssarcopeniahyperkyphosisultrasonography

Outcome Measures

Primary Outcomes (6)

  • tandem stance and gait test

    static and dynamic balance was measured.

    Data were collected over a single measurement period of 6 months.

  • berg balance scale

    Berg balance scale was originally developed for the assessment of postural control and is widely used in many areas of rehabilitation. There are 14 items in the scale, like commonly performing in daily activities sitting and standing balance, transfers, turning, and retrieving objects from the floor. The highest total score is 56 points. If the patient scores between 0-20 points, they are considered wheelchair dependent, between 21-40 points they can walk with assistance and between 41-56 points they are considered independent in mobilization activities.

    Data were collected over a single measurement period of 6 months.

  • Timed up and go test

    There is a significant relationship between TUG times and functional mobility level

    Data were collected over a single measurement period of 6 months.

  • chair stand test

    The five times CST evaluates the strength, power, and endurance of the lower extremity muscle group, particularly the quadriceps femoris muscle

    Data were collected over a single measurement period of 6 months.

  • quadriceps femoris muscle thickness

    evaluated by ultrasound

    Data were collected over a single measurement period of 6 months.

  • thoracic kyphosis

    The lateral thoracic vertebra radiographs were taken while standing position, the Cobb angle was automatically obtained by computer-aided method by marking the parallel lines drawn from the upper edge of the upper thoracic vertebra (T4), and the lower edge of the lower thoracic vertebra (T12)

    Data were collected over a single measurement period of 6 months.

Eligibility Criteria

Age50 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with Postmenopausal Osteoporosis
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 50 years and over with postmenopausal osteoporosis and/or osteoporotic vertebral fractures according to WHO criteria who applied to the outpatient clinic of the Department of Physical Medicine and Rehabilitation, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

You may qualify if:

  • Patient who were 50 years of age or older, had postmenopausal osteoporosis and/or osteoporotic vertebral fractures according to WHO criteria,
  • Patient who were able to ambulate without any assistive devices

You may not qualify if:

  • History of neurological disease which may affect balance and proprioception,
  • Visual and vestibular disease
  • Previous major lower extremity surgery or previous vertebra surgery
  • Advanced heart, liver, or renal failure
  • Stage 4 knee osteoarthritis
  • Psychiatric disorders
  • Use of any medication affecting the central nervous system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Istanbul University Cerrahpasa

Istanbul, Istanbul, 59030, Turkey (Türkiye)

Location

Istanbul University Cerrahpasa, Cerrahpasa Medical Faculty

Istanbul, SÜLEYMANPAŞA, 59030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

OsteoporosisSarcopeniaKyphosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsSpinal CurvaturesSpinal Diseases

Study Officials

  • ESLEM PEKER BELENE

    Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty

    PRINCIPAL INVESTIGATOR
  • ZEYNEP ÜLKÜ AKARIRMAK

    Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty

    STUDY DIRECTOR
  • RANA TERLEMEZ

    Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty

    STUDY CHAIR
  • OSMAN AYKAN KARGIN

    Istanbul University- Cerrahpasa, Cerrahpasa Medical Faculty

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 27, 2024

First Posted

January 7, 2025

Study Start

July 1, 2022

Primary Completion

December 31, 2022

Study Completion

November 29, 2023

Last Updated

January 8, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
12 months after publication of primary results
Access Criteria
Academic and Clinical Researchers, Regulatory Authorities and Non-commercial Researchers and Public Health Organizations can access the data Demographic and Clinical Data, Outcome Measures,Study protocols, statistical analysis plans, and publications can be accessed Submit a Request, Approval Process, Secure Access will be accessed

Locations